NCT07136948 Mindfulness Training and Respiration Biosignal Feedback - Study 2
| NCT ID | NCT07136948 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Equa Health |
| Condition | Psychological Distress |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-07-21 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-07-21 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this research is to test usability and user satisfaction with a new breathing feature on the meditation app, Equa, to help young adults who are distressed, understand their physiological responses and mindfulness skill development during meditation. Our main aims are to test an algorithm that can use physiologic signals to give feedback about how participant physiology is changing during guided lessons on the meditation app, Equa through: * Assessing user satisfaction and usability * Measuring how much participant mindfulness skills are improving Participants will: * Complete a survey about demographics, their thoughts and feelings before and after the mindfulness meditation program * Complete 14 smartphone guided mindfulness meditation training units while physiological measures are being recorded * A subset of participants will see a graph tracking their physiological responses from the guided meditation lesson and predictive mindfulness skill scores * Complete a few brief questionnaires before and after mindfulness practices to understand potential changes in their mindfulness skills
Eligibility Criteria
Inclusion Criteria: * Ages 18-30 years of Age * Fluent in English * Psychological distress * Willing to participate in guided meditation or stress management training. * Willing and able to wear earbud headphones and a shirt which uses sensors to track motion and physiological measures. * Willing to be randomized to one of two conditions * Willing to provide ratings on their training experience Exclusion Criteria: * Currently pregnant * Current or previous diagnosis with psychosis or schizophrenia
Contact & Investigator
David Creswell, Ph.D.
PRINCIPAL INVESTIGATOR
Equa Health
Frequently Asked Questions
Who can join the NCT07136948 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Psychological Distress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07136948 currently recruiting?
Yes, NCT07136948 is actively recruiting participants. Contact the research team at emily.grace@equahealth.io for enrollment information.
Where is the NCT07136948 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT07136948 clinical trial?
NCT07136948 is sponsored by Equa Health. The principal investigator is David Creswell, Ph.D. at Equa Health. The trial plans to enroll 60 participants.